Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial.

ProCase (AB002) - Aronora

http://www.ncbi.nlm.nih.gov/pubmed/39060370

Andras Gruber; Brandon D Markway; Christina U Lorentz; Enrico Di Cera; Erik I Tucker; Joseph J Shatzel; Michael Wallisch; Norah G Verbout; Thomas C Marbury

Jul 27, 2024